amifostine anhydrous has been researched along with 16,16-dimethylprostaglandin e2 in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (50.00) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Geng, L; Hanson, WR; Malkinson, FD | 1 |
Allalunis-Turner, MJ; Sawich, C; Walden, TL | 1 |
Hanson, WR | 1 |
Hughes, HN; Jackson, WE; Steel, LK; Walden, TL | 1 |
Albert, C; Henry, A; Maisin, JR | 1 |
Davis, HD; Kumar, KS; Landauer, MR; Weiss, JF | 1 |
6 other study(ies) available for amifostine anhydrous and 16,16-dimethylprostaglandin e2
Article | Year |
---|---|
Topical or systemic 16, 16 dm prostaglandin E2 or WR-2721 (WR-1065) protects mice from alopecia after fractionated irradiation.
Topics: 16,16-Dimethylprostaglandin E2; Administration, Topical; Alopecia; Amifostine; Animals; Injections, Subcutaneous; Male; Mice; Radiation Injuries, Experimental; Radiation-Protective Agents | 1992 |
Induction of marrow hypoxia by radioprotective agents.
Topics: 16,16-Dimethylprostaglandin E2; Amifostine; Animals; beta-Aminoethyl Isothiourea; Bone Marrow; Bone Marrow Cells; Cysteamine; Endotoxins; Female; Mice; Mice, Inbred BALB C; Oxygen; Radiation-Protective Agents; Serotonin; Superoxide Dismutase | 1989 |
Radiation protection of murine intestine by WR-2721, 16,16-dimethyl prostaglandin E2, and the combination of both agents.
Topics: 16,16-Dimethylprostaglandin E2; Amifostine; Animals; Cell Survival; Dose-Response Relationship, Drug; Drug Interactions; Intestinal Mucosa; Male; Mice; Organothiophosphorus Compounds; Prostaglandins E, Synthetic; Radiation-Protective Agents; Stem Cells | 1987 |
Protection of mice against mixed fission neutron-gamma (n: gamma = 1:1) irradiation by WR-2721, 16,16-dimethyl PGE2, and the combination of both agents.
Topics: 16,16-Dimethylprostaglandin E2; Amifostine; Animals; Drug Therapy, Combination; Female; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neutrons; Organothiophosphorus Compounds; Prostaglandins E, Synthetic; Radiation Injuries, Experimental; Radiation-Protective Agents | 1988 |
Reduction of short-term radiation lethality by biological response modifiers given alone or in association with other chemical protectors.
Topics: 16,16-Dimethylprostaglandin E2; Amifostine; Animals; Cysteine; Drug Therapy, Combination; Glucans; Immunologic Factors; Male; Mice; Mice, Inbred Strains; Radiation Injuries, Experimental; Serotonin | 1993 |
Behavioral toxicity of selected radioprotectors.
Topics: 16,16-Dimethylprostaglandin E2; Adjuvants, Immunologic; Amifostine; Animals; Caffeine; Central Nervous System Stimulants; Cord Factors; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glucans; Interleukin-1; Leukotriene C4; Male; Mice; Motor Activity; Phospholipids; Platelet Activating Factor; Radiation-Protective Agents; Sulfhydryl Compounds | 1992 |